These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 32233054

  • 1. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
    Sun Y, Bai H, Xia W, Wang D, Zhou B, Zhao X, Yang G, Xu L, Zhang W, Liu P, Xu J, Meng S, Liu R, Gao X.
    J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
    [Abstract] [Full Text] [Related]

  • 2. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
    Song W, Yu X, Guo D, Liu H, Tang Z, Liu X, Zhou J, Zhang H, Liu Y, Liu X.
    J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
    [Abstract] [Full Text] [Related]

  • 3. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Zhao Y, Wu J, Zhang Q, Hua Z, Qi W, Wang N, Lin T, Sheng L, Cui D, Liu J, Song Q, Li X, Wu T, Guo Y, Cui J, Liu A.
    J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
    [Abstract] [Full Text] [Related]

  • 4. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C, Zhao Z, Chen W, Lv X, Shu G, Ye M, Song J, Ying X, Weng Q, Weng W, Fang S, Chen M, Tu J, Ji J.
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [Abstract] [Full Text] [Related]

  • 5. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
    Luo J, Huang Z, Wang M, Li T, Huang J.
    BMC Gastroenterol; 2022 Mar 08; 22(1):108. PubMed ID: 35260095
    [Abstract] [Full Text] [Related]

  • 6. Prediction Model for Intermediate-Stage Hepatocellular Carcinoma Response to Transarterial Chemoembolization.
    Jia F, Wu B, Yan R, Li L, Wang K, Han D.
    J Magn Reson Imaging; 2020 Dec 08; 52(6):1657-1667. PubMed ID: 32424881
    [Abstract] [Full Text] [Related]

  • 7. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX, Li CF, Zhao LF, Sun ZQ, Cui LM, Xin YJ, Wang DQ, Kang TR, Jiang HJ.
    Hepatobiliary Pancreat Dis Int; 2024 Aug 08; 23(4):361-369. PubMed ID: 37429785
    [Abstract] [Full Text] [Related]

  • 8. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology].
    Weng W, Lü XL, Zhang QQ, Zhao XM, Chen CM, Kong CL, Lu CY, Chen MJ, Ji JS.
    Zhonghua Yi Xue Za Zhi; 2020 Mar 24; 100(11):828-832. PubMed ID: 32234153
    [Abstract] [Full Text] [Related]

  • 9. Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.
    Xi Z, Ye Y, Yang Y, He Y, Song Z, Ma Q, Zeng H, Shao G.
    Abdom Radiol (NY); 2024 Jul 24; 49(7):2387-2400. PubMed ID: 39030402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment.
    Zhang H, He X, Yu J, Song W, Liu X, Liu Y, Zhou J, Guo D.
    Br J Radiol; 2019 Jul 24; 92(1099):20190073. PubMed ID: 31166700
    [Abstract] [Full Text] [Related]

  • 12. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
    Kuang Y, Li R, Jia P, Ye W, Zhou R, Zhu R, Wang J, Lin S, Pang P, Ji W.
    Abdom Radiol (NY); 2021 Aug 24; 46(8):3772-3789. PubMed ID: 33713159
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL, Zheng JP, Guo LW, Chen YT, Zeng H, Yao Z.
    Medicine (Baltimore); 2017 Jan 24; 96(3):e5518. PubMed ID: 28099329
    [Abstract] [Full Text] [Related]

  • 14. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D, Xie Y, Wei J, Li W, Ye Z, Zhu Z, Tian J, Li X.
    J Magn Reson Imaging; 2020 Dec 24; 52(6):1679-1687. PubMed ID: 32491239
    [Abstract] [Full Text] [Related]

  • 15. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
    Liu K, Zheng X, Lu D, Tan Y, Hou C, Dai J, Shi W, Jiang B, Yao Y, Lu Y, Cao Q, Chen R, Zhang W, Xie J, Chen L, Jiang M, Zhang Z, Liu L, Liu J, Li J, Lv W, Wu X.
    Radiol Med; 2024 Jan 24; 129(1):14-28. PubMed ID: 37863847
    [Abstract] [Full Text] [Related]

  • 16. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
    Tang TY, Li X, Zhang Q, Guo CX, Zhang XZ, Lao MY, Shen YN, Xiao WB, Ying SH, Sun K, Yu RS, Gao SL, Que RS, Chen W, Huang DB, Pang PP, Bai XL, Liang TB.
    J Magn Reson Imaging; 2020 Jul 24; 52(1):231-245. PubMed ID: 31867839
    [Abstract] [Full Text] [Related]

  • 17. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S, Xie H, Wang H, Han C, Yang J, Lin Z, Li Y, He Q, Wang R, Cui Y, Zhang X, Wang X.
    J Magn Reson Imaging; 2019 Dec 24; 50(6):1914-1925. PubMed ID: 31062459
    [Abstract] [Full Text] [Related]

  • 18. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM, Han YQ, Wei JW, Qi YF, Gu DS, Lei J, Yan WG, Xiao Y, Xue HD, Feng F, Sun H, Jin ZY, Tian J.
    J Magn Reson Imaging; 2020 Oct 24; 52(4):1239-1248. PubMed ID: 32181985
    [Abstract] [Full Text] [Related]

  • 19. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, Khoshpouri P, Shao N, Pan L, Grimm R, Kamel IR.
    J Magn Reson Imaging; 2018 Oct 24; 48(4):1080-1090. PubMed ID: 29630756
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.